Roche signs agreement to acquire Verum Diagnostica

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has signed an agreement under which it will acquire 100 percent of Verum Diagnostica GmbH, based in Munich, Germany. Verum Diagnostica is a leading company in platelet function testing, the fastest-growing field in the coagulation diagnostics market.

The acquisition supports plans Roche announced in October to expand its coagulation testing product line in North America beyond physician offices and outpatient clinics with the development of a full line of coagulation analyzers for hospital and reference laboratories. The new line is expected to be introduced in the U.S. and Canada in 2014, subject to regulatory approval and other requirements.

"Improving the assessment of a patient's platelet function status is currently a significant unmet need for hematologists, cardiologists and anesthetists in order to support clinical decisions in cardiology, surgery and intensive care," said Colin Brown, Head of Roche Professional Diagnostics. "With this acquisition we gain an innovative and unique platelet function testing solution which has the potential to set new standards of patient care in this area and perfectly complements our new coagulation portfolio." Coagulation diagnostics has become an important area in clinical diagnostics and Roche has already begun to make significant investments in this field.

Under the terms of the acquisition agreement, Roche will pay Verum Diagnostica shareholders a total cash consideration of eleven million euros, and potentially a further two million euros contingent upon reaching certain performance-related milestones. The transaction is subject to customary closing conditions and is expected to close in January 2012.

Laboratory coagulation is estimated to be the fifth-largest market in professional diagnostics worldwide, representing approximately 1.3 billion USD in sales in 2010 and having a projected annual growth rate of 5.1% over the next five years. Platelet function testing represents an unmet medical need and has the potential to expand the available market significantly.

SOURCE Roche Diagnostics

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Roche Diagnostics Limited. (2018, July 27). Roche signs agreement to acquire Verum Diagnostica. News-Medical. Retrieved on December 01, 2020 from https://www.news-medical.net/news/20111206/Roche-signs-agreement-to-acquire-Verum-Diagnostica.aspx.

  • MLA

    Roche Diagnostics Limited. "Roche signs agreement to acquire Verum Diagnostica". News-Medical. 01 December 2020. <https://www.news-medical.net/news/20111206/Roche-signs-agreement-to-acquire-Verum-Diagnostica.aspx>.

  • Chicago

    Roche Diagnostics Limited. "Roche signs agreement to acquire Verum Diagnostica". News-Medical. https://www.news-medical.net/news/20111206/Roche-signs-agreement-to-acquire-Verum-Diagnostica.aspx. (accessed December 01, 2020).

  • Harvard

    Roche Diagnostics Limited. 2018. Roche signs agreement to acquire Verum Diagnostica. News-Medical, viewed 01 December 2020, https://www.news-medical.net/news/20111206/Roche-signs-agreement-to-acquire-Verum-Diagnostica.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Roche establishes strategic alliance with Diagnostic Laboratory Services